MRK – Merck & Co Stock Premarket Price
MRK Premarket Chart
About Merck & Co Inc
Merck & Co. Inc. is a renowned multinational pharmaceutical company. Founded in 1891, Merck is recognized for its contributions to the healthcare sector, including the development of prescription drugs and vaccines. The company’s products address a wide range of medical conditions and health challenges. Merck’s commitment to medical research and innovation has led to significant advancements in the field of pharmaceuticals. As a leader in the healthcare industry, Merck continues to play a crucial role in improving global health and well-being.
Latest News
- Piper Sandler says Strait of Hormuz to remain closed for months and oil to hit new highs
- Pope Leo is concerned about AI replacing human work. Traders share his concern long term
- Stocks making the biggest moves premarket: Ferrari, Lear, Intuitive Machines, Micron Technology and more
- Huawei plans new smartphone chips this fall as rivalry with Nvidia and Apple heats up
- China tech plays to ride out macro volatility
- Three signs from APEC that the U.S. and China remain far apart on trade
- Kevin Warsh’s real Fed ‘regime change’ may happen deep inside Wall Street’s plumbing
- Which company will the U.S. government take a stake in next? Here’s what traders think
- Surge in ‘risk-free’ treasury yields sends bond investors in search of better opportunities
- Despite murky legal landscape, companies are undeterred in their prediction market investments
- Stocks making the biggest moves premarket: IMAX, Merck, Estee Lauder & more
- U.S. pushes its AI in China and Asia after Trump-Xi meeting
- China calls for APEC cooperation as commerce minister skips opening over ‘urgent official business’
- Miner Perpetua Resources secures $2.9 billion U.S. loan for Idaho gold, antimony project
- Prediction markets are fueling a high-stakes brawl between states and federal regulators
- Stocks making the biggest moves after hours: Zscaler, Insulet, Box and more
- Lenovo shares jump nearly 20% on record earnings as AI revenue nearly doubles
- Stocks making the biggest moves after hours: Workday, Estee Lauder, Zoom, Take-Two and more
- Workday jumps 10% as it bumps up margin forecast on AI strength
- Here we go again with Nvidia falling on earnings. What the sellers are missing
- Ubisoft shares plunge 16% after Assassin’s Creed maker warns of annual profit loss
- Walmart to report first-quarter earnings before the bell. Here’s what Wall Street expects
- We’re raising our price target on Nvidia after another knockout quarter and guide
- Anthropic set to hit $10.9 billion in revenue during second quarter, source says
- E.l.f. Beauty to walk back some tariff price increases amid high gas prices and consumer ‘suffering’
- Intuit plans to cut workforce by about 17% as tax software maker reckons with slowing growth
- TJX shows it’s the right retail stock for this moment with a stellar quarter, guidance boost
- Lowe’s beats Wall Street expectations against ‘challenging’ housing backdrop
- Target is set to report first-quarter earnings, offer read on consumer
- Home Depot was a mistake but selling it now would compound it. Why we’re hanging on